Sign inJoin waitlistJoin the waitlist

Funda Meric-Bernstam

Research Fellowship Director · University of Texas M D Anderson Cancer Center

Credentials: · · · · ·

History

Research Fellowship · University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Complex General Surgical Oncology
University of Texas M D Anderson Cancer Center
1998–2001
University of Texas M D Anderson Cancer Center
1999–2000
General Surgery
University of Michigan
1996–1998
National Institute of Health
1994–1996
Clinical Informatics
1991–1993
Yale Univ Sch of Med
1987–1991

Research

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
New England Journal of Medicine · 2018 · 2,193 citations
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
New England Journal of Medicine · 2020 · 1,421 citations
PD-L1 expression in triple-negative breast cancer
Cancer Immunology Research · 2014 · 1,143 citations

Kelly Hunt
143 papers
David Hong
133 papers
Sarina Piha-Paul
124 papers
Henry Kuerer
111 papers
Vivek Subbiah
110 papers
Aung Naing
109 papers
Siqing Fu
103 papers
FJ
Filip Janku
99 papers
Gordon Mills
90 papers
Apostolia Tsimberidou
84 papers
Gabriel Hortobagyi
80 papers
GB
Gildy Babiera
80 papers

Grants

Center for Clinical and Translational Sciences
National Center for Advancing Translational Sciences · UM1
PI · $16.7M · University of Texas Hlth Sci Ctr Houston
2024–2031
The University of Texas MD Anderson Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $237.1K · University of Tx Md Anderson Can Ctr
1996–2031
Training of Academic Surgical Oncologists
National Cancer Institute · T32
Contact PI · $6.5M · University of Tx Md Anderson Can Ctr
1994–2028
A Phase II Multi-Center Trial Evaluating Dual Targeting of the PI3K/AKT and NOS Pathways for Treating Metaplastic Breast Cancer (MpBC)
National Cancer Institute · U01
PI · $2M · Methodist Hospital Research Institute
2022–2027

Clinical trials

Chatbot Implementation In The Clinical Informed Consent Process
Principal investigator · Not yet recruiting
M.D. Anderson Cancer Center
2027–2031
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
Principal investigator · Recruiting · Phase 1
National Cancer Institute (NCI)
2025–2027
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Principal investigator · Recruiting · Phase 1, Phase 2
AstraZeneca
2023–2028